Ontology highlight
ABSTRACT:
SUBMITTER: Sifrim A
PROVIDER: S-EPMC5988037 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature
Sifrim Alejandro A Hitz Marc-Phillip MP Wilsdon Anna A Breckpot Jeroen J Turki Saeed H Al SH Thienpont Bernard B McRae Jeremy J Fitzgerald Tomas W TW Singh Tarjinder T Swaminathan Ganesh Jawahar GJ Prigmore Elena E Rajan Diana D Abdul-Khaliq Hashim H Banka Siddharth S Bauer Ulrike M M UM Bentham Jamie J Berger Felix F Bhattacharya Shoumo S Bu'Lock Frances F Canham Natalie N Colgiu Irina-Gabriela IG Cosgrove Catherine C Cox Helen H Daehnert Ingo I Daly Allan A Danesh John J Fryer Alan A Gewillig Marc M Hobson Emma E Hoff Kirstin K Homfray Tessa T Kahlert Anne-Karin AK Ketley Ami A Kramer Hans-Heiner HH Lachlan Katherine K Lampe Anne Katrin AK Louw Jacoba J JJ Manickara Ashok Kumar AK Manase Dorin D McCarthy Karen P KP Metcalfe Kay K Moore Carmel C Newbury-Ecob Ruth R Omer Seham Osman SO Ouwehand Willem H WH Park Soo-Mi SM Parker Michael J MJ Pickardt Thomas T Pollard Martin O MO Robert Leema L Roberts David J DJ Sambrook Jennifer J Setchfield Kerry K Stiller Brigitte B Thornborough Chris C Toka Okan O Watkins Hugh H Williams Denise D Wright Michael M Mital Seema S Daubeney Piers E F PE Keavney Bernard B Goodship Judith J Abu-Sulaiman Riyadh Mahdi RM Klaassen Sabine S Wright Caroline F CF Firth Helen V HV Barrett Jeffrey C JC Devriendt Koenraad K FitzPatrick David R DR Brook J David JD Hurles Matthew E ME
Nature genetics 20160801 9
Congenital heart defects (CHDs) have a neonatal incidence of 0.8-1% (refs. 1,2). Despite abundant examples of monogenic CHD in humans and mice, CHD has a low absolute sibling recurrence risk (∼2.7%), suggesting a considerable role for de novo mutations (DNMs) and/or incomplete penetrance. De novo protein-truncating variants (PTVs) have been shown to be enriched among the 10% of 'syndromic' patients with extra-cardiac manifestations. We exome sequenced 1,891 probands, including both syndromic CHD ...[more]